Though many COVID-19 drug and vaccine trials are under way today, there's no guarantee that they will be successful in the next year (or longer). Meanwhile, the long pandemic could also have huge, lasting effects, harming many industries, while also boosting the stocks of certai
With so many people staying home during the COVID-19 pandemic and needing to entertain themselves, Netflix (NASDAQ: NFLX) has emerged as an inadvertent beneficiary of the public health crisis. The video-streaming leader posted a massive (if unsurprising) spike in subscriber addi
With so many people staying home during the COVID-19 pandemic and needing to entertain themselves, Netflix (NASDAQ: NFLX) has emerged as an inadvertent beneficiary of the public health crisis. The video-streaming leader posted a massive (if unsurprising) spike in subscriber addi
The entertainment sector has been complicated in 2020. Some stocks crashed due to the COVID-19 pandemic, others surged because the same health crisis actually helped them, and many are stuck in between those extremes.
The entertainment sector has been complicated in 2020. Some stocks crashed due to the COVID-19 pandemic, others surged because the same health crisis actually helped them, and many are stuck in between those extremes.
Despite the brutal economic conditions that still have much of the economy on the sidelines, and the resurgence of COVID-19 cases in recent weeks, some of the most beaten-down stocks are leading today's charge higher for the S&P 500 (SNPINDEX: ^GSPC). The index ended the w
Despite the brutal economic conditions that still have much of the economy on the sidelines, and the resurgence of COVID-19 cases in recent weeks, some of the most beaten-down stocks are leading today's charge higher for the S&P 500 (SNPINDEX: ^GSPC). The index ended the w
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.
U.S. stocks rose on Friday and the Nasdaq posted its sixth record closing high in seven days as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 soothed investor worries over a record rise in coronavirus cases in the United States.
U.S. stocks rose on Friday and the Nasdaq posted its sixth record closing high in seven days as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 soothed investor worries over a record rise in coronavirus cases in the United States.
What happened
Netflix (NASDAQ: NFLX) shares were flying higher today after investors woke up to a full-throated endorsement from Goldman Sachs. Analyst Heath Terry raised his price target on the stock from $540 to $670, and once again said it was on his Conviction Buy list.
What happened
Netflix (NASDAQ: NFLX) shares were flying higher today after investors woke up to a full-throated endorsement from Goldman Sachs. Analyst Heath Terry raised his price target on the stock from $540 to $670, and once again said it was on his Conviction Buy list.
U.S. stocks rose on Friday as a positive update from Gilead Sciences Inc's antiviral drug to treat COVID-19 countered nerves over a record rise in coronavirus cases in the United States that threatens to further impact companies.
U.S. stocks rose on Friday as a positive update from Gilead Sciences Inc's antiviral drug to treat COVID-19 countered nerves over a record rise in coronavirus cases in the United States that threatens to further impact companies.
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Netflix Inc (Symbol: NFLX), where a total of 346,738 contracts have traded so far, representing approximately 34.7 million underlying shares. That amounts to about 584%
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Netflix Inc (Symbol: NFLX), where a total of 346,738 contracts have traded so far, representing approximately 34.7 million underlying shares. That amounts to about 584%
BNK Invest
Checked
30 minutes 52 seconds ago
This feed is responsible for generating the rss feed related to the topic NFLX